Biotech Beat Nvidia in 2025. Can It Do It Again?

Big pharma and biotech take the earnings stage with reports from Eli Lilly and Novo Nordisk leading the lineup. Will they help the industry once again outperform AI champ Nvidia?In this podcast, Motley Fool analysts Karl Thiel, Tom King, and Tim Beyers discuss:Slow rolling chaos at the FDA and its effects on drug approvals.How to think about risk when investing in biotech.A review of results from DNA researcher Twist Bioscience.Don't wait! Be sure to get to your favorite bookseller and pick up a copy of Dav ...